# Programmable CRISPR‐Cas transcriptional activation in bacteria

**Authors:** Hsing‐I Ho, Jennifer R Fang, Jacky Cheung, Harris H Wang

PMC · DOI: 10.15252/msb.20199427 · 2020-07-13

## TL;DR

A new CRISPR-based system allows precise control of gene expression in bacteria, enabling both activation and repression of genes.

## Contribution

The development of dCas9-AsiA, a novel CRISPR activator that enables strong and programmable gene regulation in bacteria.

## Key findings

- dCas9-AsiA can activate gene expression by over 200-fold across diverse promoters in E. coli.
- The system allows simultaneous activation and repression of bacterial regulons.
- dCas9-AsiA can be applied to other bacteria of clinical and industrial importance.

## Abstract

Programmable gene activation enables fine‐tuned regulation of endogenous and synthetic gene circuits to control cellular behavior. While CRISPR‐Cas‐mediated gene activation has been extensively developed for eukaryotic systems, similar strategies have been difficult to implement in bacteria. Here, we present a generalizable platform for screening and selection of functional bacterial CRISPR‐Cas transcription activators. Using this platform, we identified a novel CRISPR activator, dCas9‐AsiA, that could activate gene expression by more than 200‐fold across genomic and plasmid targets with diverse promoters after directed evolution. The evolved dCas9‐AsiA can simultaneously mediate activation and repression of bacterial regulons in E. coli. We further identified hundreds of promoters with varying basal expression that could be induced by dCas9‐AsiA, which provides a rich resource of genetic parts for inducible gene activation. Finally, we show that dCas9‐AsiA can be ported to other bacteria of clinical and bioindustrial relevance, thus enabling bacterial CRISPRa in more application areas. This work expands the toolbox for programmable gene regulation in bacteria and provides a useful resource for future engineering of other bacterial CRISPR‐based gene regulators.

An evolved CRISPR‐based bacterial transcription activator system enables programmable and combinatorial gene expression modulation in diverse bacteria.

## Full-text entities

- **Genes:** MCP [NCBI Gene 18983507], asiA (anti-sigma factor) [NCBI Gene 1258709]
- **Diseases:** antibiotic (MESH:D004761), toxicity (MESH:D064420)
- **Chemicals:** spectinomycin (MESH:D000198), anhydrotetracycline (MESH:C016229), aTc (MESH:C003438), carbenicillin (MESH:D002228), kanamycin (MESH:D007612), Bleo (MESH:D001761), CRISPRa (-), chloramphenicol (MESH:D002701)
- **Species:** Klebsiella oxytoca (species) [taxon 571], Pedobacter borealis (species) [taxon 475254], Homo sapiens (human, species) [taxon 9606], Escherichia coli (E. coli, species) [taxon 562], Salmonella enterica (species) [taxon 28901], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Streptococcus pyogenes (species) [taxon 1314], Tequatrovirus T4 (species) [taxon 10665]
- **Mutations:** V58I, M0492S, Q51R, E60K, G32A
- **Cell lines:** S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), pEB2 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_A628), MG1655 — Homo sapiens (Human), Maple syrup urine disease, Transformed cell line (CVCL_D514), BW25113 — Mus musculus (Mouse), Hepatocellular carcinoma of the mouse, Cancer cell line (CVCL_X356), pHH39 — Mus musculus (Mouse), Hybridoma (CVCL_XX77)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC7356669/full.md

---
Source: https://tomesphere.com/paper/PMC7356669